Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome

被引:0
作者
Laurens J. M. Evers
Therese A. M. J. van Amelsvoort
Jaap A. Bakker
Mariken de Koning
Marjan Drukker
Leopold M. G. Curfs
机构
[1] Koraalgroup,Governor Kremers Centre
[2] MFCG,Department of Psychiatry and Psychology, School for Mental Health and Neuroscience MHeNS
[3] Maastricht University Medical Centre,Department Clinical Genetics
[4] Maastricht University Medical Centre,Department of Clinical Chemistry and Laboratory Medicine
[5] Mondriaan Mental Healthcare,Department of Psychiatry, Academic Medical Centre
[6] Virenze Mental Healthcare,CAPHRI, School for Public Health and Primary Care
[7] Maastricht University Medical Centre,GROW School for Oncology and Developmental Biology
[8] Leiden University Medical Centre,undefined
[9] University of Amsterdam,undefined
[10] Arkin Mental Health Care,undefined
[11] Maastricht University,undefined
[12] Maastricht University,undefined
来源
Psychopharmacology | 2015年 / 232卷
关键词
Proline; Glutamate; Glutamine; 22q11 deletion syndrome; Age; Cognition; Psychosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3319 / 3325
页数:6
相关论文
共 289 条
[1]  
Alfredsson G(1988)Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers Biol Psychiatry 23 689-697
[2]  
Wiesel FA(2003)Glutamate and the glutamate receptor system: a target for drug action Int J Geriatr Psychiatry 18 S33-S40
[3]  
Tylec A(2010)Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: potential role for dopamine transporter imaging Am J Med Genet A 152a 2937-2938
[4]  
Bleich S(2013)Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications JAMA Neurol 70 1359-1366
[5]  
Romer K(1988)Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity Annu Rev Neurosci 11 61-80
[6]  
Wiltfang J(2011)Proton magnetic resonance spectroscopy in 22q11 deletion syndrome PLoS One 6 e21685-2945
[7]  
Kornhuber J(2013)Cognitive and behavioral trajectories in 22q11DS from childhood into adolescence: a prospective 6-year follow-up study Res Dev Disabil 34 2937-1165
[8]  
Booij J(2014)Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome Int J Neuropsychopharmacol 17 1159-925
[9]  
van Amelsvoort T(2014)Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability J Intellect Disabil Res 58 915-497
[10]  
Boot E(2002)Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine Biol Psychiatry 51 493-848